Concepedia

Publication | Open Access

HSP60 may Predict Good Pathological Response to Neoadjuvant Chemoradiotherapy in Bladder Cancer

DOIFull Paper Access

34

Citations

17

References

2006

Year

Masayasu Urushibara, Y. Kageyama, Takumi Akashi, Yoshihito Otsuka, T Takizawa, Masato Koike, K. Kihara
Japanese Journal of Clinical Oncology

Abstract

Positive HSP60 expression prior to CRT may predict good pathological response to low-dose neoadjuvant CRT in invasive or high-risk superficial bladder cancer.

References

YearCitations

Page 1